BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events
BIVI Stock | USD 1.67 0.02 1.21% |
Under 65% of Biovie's investor base is looking to short. The analysis of the overall investor sentiment regarding Biovie Inc suggests that many traders are alarmed. Biovie's investing sentiment shows overall attitude of investors towards Biovie Inc.
Biovie |
NEW YORK, NY ACCESSWIRE January 13, 2025 New to The Street, a leading FMW Media production, is thrilled to announce its partnership with BioVie Inc. , a clinical-stage biopharmaceutical company developing innovative therapies for ...
Read at finance.yahoo.com
Biovie Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Biovie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biovie Fundamental Analysis
We analyze Biovie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Biovie is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Biovie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biovie stock to make a market-neutral strategy. Peer analysis of Biovie could also be used in its relative valuation, which is a method of valuing Biovie by comparing valuation metrics with similar companies.
Peers
Biovie Related Equities
XFOR | X4 Pharmaceuticals | 6.06 | ||||
AMLX | Amylyx Pharmaceuticals | 3.99 | ||||
MREO | Mereo BioPharma | 2.73 | ||||
INZY | Inozyme Pharma | 1.37 | ||||
HOOK | Hookipa Pharma | 2.00 | ||||
DAWN | Day One | 3.81 | ||||
ABOS | Acumen Pharmaceuticals | 3.85 | ||||
TERN | Terns Pharmaceuticals | 3.88 | ||||
ELDN | Eledon Pharmaceuticals | 5.44 |
Complementary Tools for Biovie Stock analysis
When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Transaction History View history of all your transactions and understand their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |